Acute pancreatitis: Assessment of severity with clinical and CT evaluation

Radiology

Volumn 223, Issue 3, 2002, Pages 603-613

  Balthazar, Emil J ^a  

^a BELLEVUE HOSPITAL CENTER   (United States)

Author keywords

Pancreas, CT; Pancreatitis; Review

Indexed keywords

CONTRAST MEDIUM;

ACUTE PANCREATITIS; CARDIOVASCULAR DISEASE; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; INFLAMMATION; KIDNEY FAILURE; LUNG INSUFFICIENCY; MULTIPLE ORGAN FAILURE; PANCREAS INJURY; PANCREAS NECROSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RATING SCALE; REVIEW; SENSITIVITY ANALYSIS; STAGING;

EID: 0036098977     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2233010680     Document Type: Review

References (85)

1. A clinically based classification system for acute pancreatitis
2. Diagnosis, objective assessment of severity, and management of acute pancreatitis
3. The management of acute pancreatitis: A critical assessment as Dr. Bockus would have wished
4. Prognostic factors in acute pancreatitis
5. Acute pancreatitis: Medical and surgical management
6. Practice guidelines in acute pancreatitis
7. Assessment of severity in acute pancreatitis
8. Natural course of acute pancreatitis
9. A new classification system for acute pancreatitis
10. Classification of pancreatitis
11. Revised classification of pancreatitis
12. The pancreatitis classification of Marseille: Rome, 1988
13. Definitions and classification of pancreatitis
14. Pathology of severe acute pancreatitis
15. Ischemic necrotizing pancreatitis
16. Risk factors for pancreatic cellular injury after cardiopulmonary bypass
17. Susceptibility of the pancreas to ischemic injury in shock
18. Native and graft pancreatitis following combined pancreas-renal transplantation
19. Incremental dynamic bolus computed tomography of acute pancreatitis
20. Pancreatic necrosis develops within four days after the acute attack
21. Trypsinogen activation peptides (TAP) concentrations in the peritoneal fluid of patients with acute pancreatitis and their relation to the presence of histologically confirmed pancreatic necrosis
22. C-reactive protein (CRP) and serum phospholipase A in the assessment of the severity of acute pancreatitis
23. PMN-elastase in comparison with CRP, antiproteases and LDH as indicators of necrosis in human acute pancreatitis
24. C-reactive protein, anti-proteases and complement factors as objective markers of severity in acute pancreatitis
25. Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis
26. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis
27. The potential role of therapeutic cytokine manipulation in acute pancreatitis
28. Death due to acute pancreatitis: A retrospective analysis of 405 autopsy cases
29. Increased body weight as a prognostic parameter for complications in the course of acute pancreatitis
30. Obesity as a predictor of severity in acute pancreatitis
31. Obesity: An important prognostic factor in acute pancreatitis
32. The incidence and prognosis of body wall ecchymosis in acute pancreatitis
33. A comparative study of methods for the prediction of severity of attacks of acute pancreatitis
34. Prediction of outcome in acute pancreatitis: A comparative study of APACHE II, clinical assessment and multiple factor scoring systems
35. Prediction of severity in acute pancreatitis: Prospective comparison of three prognostic indices
36. Serum trypsinogen-2 in the prediction of outcome in acute necrotizing pancreatitis
37. Methemalbumin in acute pancreatitis: An evaluation of its prognostic value and comparison with multiple prognostic parameters
38. Serum ribonuclease elevations and pancreatic necrosis in acute pancreatitis
39. Serum ribonuclease activity in the diagnosis of pancreatic disease
40. Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis
41. Serum tumour necrosis factor compared with C-reactive protein in the assessment of severity of acute pancreatitis
42. Serum concentration of inflammatory mediators related to organ failure with acute pancreatitis
43. The role of phospholipase A in acute pancreatitis
44. Role of phospholipase A2 in human acute pancreatitis
45. Serum phospholipase A2 activity in acute pancreatitis: An early guide to severity
46. Clinical usefulness of polymorphonuclear elastase in predicting the severity of acute pancreatitis: Results of a multicentre study
47. C-reactive protein: An aid to assessment and monitoring acute pancreatitis
48. C-reactive protein, anti-proteases and complement factors as objective markers of severity in acute pancreatitis
49. Controlled clinical trial of peritoneal lavage for the treatment of severe acute pancreatitis
50. Risk factors in acute pancreatitis
51. Objective early identification of severe acute pancreatitis
52. Prognostic factors in acute pancreatitis
53. Simplified prognostic criteria in acute pancreatitis
54. APACHE II: A severity of disease classification system
55. APACHE II score for assessment and monitoring of acute pancreatitis
56. Prediction of outcome in acute pancreatitis: A comparative study of APACHE-II clinical assessment and multiple factor scoring systems
57. Risk of death from acute pancreatitis
58. Peripheral leukocyte count and chest x-ray in the early assessment of the severity of acute pancreatitis
59. Renal function and chest x-rays in the assessment of 539 acute pancreatitis patients
60. Respiratory complications of acute pancreatitis
61. Do plain films of the chest and abdomen have a role in the diagnosis of acute pancreatitis?
62. Sonography in acute pancreatitis
63. Extrapancreatic spread of acute pancreatitis: New observations with real-time ultrasound
64. CT of acute pancreatitis: Interim assessment
65. Acute pancreatitis: Clinical vs. CT findings
66. Early computerized tomography as a predictor of outcome in acute pancreatitis
67. Acute pancreatitis: Prognostic value of CT
68. Value of contrast-enhanced computerized tomography in the early diagnosis and prognosis of acute pancreatitis
69. Contrast-enhanced abdominal computed tomography scanning and prediction of severity of acute pancreatitis: A prospective study
70. Early detection of acute fulminant pancreatitis by contrast enhanced computed tomography
71. How do imaging methods influence the surgical strategy in acute pancreatitis?
72. Early objective diagnosis and staging of acute pancreatitis by contrast enhanced CT
73. Prediction of pancreatic necrosis by dynamic pancreatography
74. Acute pancreatitis: Value of CT in establishing prognosis
75. Acute pancreatitis complicated by gland necrosis: Spectrum of findings on contrast-enhanced CT
76. CT of acute pancreatitis: Correlation between lack of contrast enhancement and pancreatic necrosis
77. Pancreatitis complicated by gland necrosis: Evolution of findings on contrast-enhanced CT
78. Imaging and intervention in acute pancreatitis
79. Acute pancreatitis: Evaluation of the prognostic criteria of the latest Balthazar tomographic classification
80. Added value of CT criteria compared to the clinical SAP score in patients with acute pancreatitis
81. The APACHE II score on admission to hospital is unreliable to diagnose necrotizing and thus severe pancreatitis
82. Acute pancreatitis: Interobserver agreement and correlation of CT and MR cholangiopancreatography with outcome
83. Pancreatic fluid collections prior to intervention: Evaluation with MR imaging compared with CT and US
84. MR pancreatography: A useful tool for evaluating pancreatic disorders
85. MR imaging of the pancreas